Difference between revisions of "Derache A, et al, Clin. Infect. Dis. (2019), cited as Ref 37 in DOI: 10.3390/v12020211 (Q10116)"
Jump to navigation
Jump to search
(Added reference to claim: title (P93): Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial, #quickstatements; #temporary_b...) |
(Created claim: Published In Name String (P102): Clin. Infect. Dis., #quickstatements; #temporary_batch_1590456335858) |
||
| Property / Published In Name String | |||
| + | Clin. Infect. Dis. | ||
| Property / Published In Name String: Clin. Infect. Dis. / rank | |||
| + | Normal rank | ||
Revision as of 01:27, 26 May 2020
Cited in: "Current Trends in Diagnostics of Viral Infections of Unknown Etiology" Viruses; 2020 Feb 14 ; 12 (2)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Derache A, et al, Clin. Infect. Dis. (2019), cited as Ref 37 in DOI: 10.3390/v12020211
|
Cited in: "Current Trends in Diagnostics of Viral Infections of Unknown Etiology" Viruses; 2020 Feb 14 ; 12 (2)
|
Statements
Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial (English)
Clin. Infect. Dis.
0 references
